Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
06/2003
06/19/2003WO2003050537A1 Diagnostic testing process
06/19/2003WO2003050536A2 Methods and apparatus for separation of blood components
06/19/2003WO2003050535A2 Method for determining the influence of non-physiological compounds the derivatives and decomposition products thereof on organisms organs and cells
06/19/2003WO2003050534A1 Test meter calibration
06/19/2003WO2003050533A1 Systems and methods for obtaining data correlated patient samples
06/19/2003WO2003050532A1 Blood cell separation system
06/19/2003WO2003050531A2 Method for displaying loops from immunoglobulin domains in different contexts
06/19/2003WO2003050530A2 Use of microwaves in the spinning industry for measuring sliver mass
06/19/2003WO2003050529A1 Method of and apparatus for measuring the water content of crude oil
06/19/2003WO2003050528A1 Diagnostic for early stage alzheimer's disease
06/19/2003WO2003050526A2 Gas sensor and method for the detection of hydrogen according to the principle of work function measurement, and method for the production of such a gas sensor
06/19/2003WO2003050524A1 Method for identifying biochemical material
06/19/2003WO2003050522A1 Method and apparatus for use of thermally switching proteins in sensing and detecting devices
06/19/2003WO2003050511A1 Volatile organic compound sensor system
06/19/2003WO2003050508A1 Method and device for preparing sample slide
06/19/2003WO2003050504A2 Methods and compositions to treat cardiovascular disease usin g 1419, 58765 and 2201
06/19/2003WO2003050503A2 Multiple binding moiety chromatography device, methods of using and methods of making same
06/19/2003WO2003050502A2 Prospective identification and characterization of breast cancer stem cells
06/19/2003WO2003050500A1 Early diagnosis of cancer or precancerous conditions by leakage of signature peptides and carbohydrates into the bloodstream
06/19/2003WO2003050499A2 Use of a labeled ligand having human cd4 specificity
06/19/2003WO2003050389A2 Apparatus and methods for downhole determination of characteristics of formation fluids
06/19/2003WO2003050304A1 Annealing control primer system for regulating primer annealing specificity and its applications
06/19/2003WO2003050302A2 Tgnp activity or expression as marker for apoptosis
06/19/2003WO2003050301A2 Susceptibility locus for schizophrenia
06/19/2003WO2003050298A1 Low molecular weight heparin assay, system and reagent therefor
06/19/2003WO2003050297A1 Methods of screening for toxicity of test compounds
06/19/2003WO2003050296A2 Method for determining the activity of ornithine decarboxylase and for identifying effectors of ornithine decarboxylase activity
06/19/2003WO2003050295A2 Assays and implements for determining and modulating hsp90 binding activity
06/19/2003WO2003050293A2 hGC-1, A GENE ENCODING A MEMBER OF THE OLFACTOMEDIN-RELATED PROTEIN FAMILY
06/19/2003WO2003050292A2 Method for reducing non-specific aggregation of latex microparticles in the presence of serum or plasma
06/19/2003WO2003050291A2 Sensor for the use in testing biological chemical or environmental samples
06/19/2003WO2003050290A2 Phosphoromonothioate and phosphorodithioate oligonucleotide aptamer chip for functional proteomics
06/19/2003WO2003050287A2 Method for modifying plant morphology, biochemistry and physiology comprising expression of plant cytokinin oxidase
06/19/2003WO2003050283A2 A structure for presenting desired peptide sequences
06/19/2003WO2003050276A1 Method for immobilizing a biologic in a polyurethane-hydrogel composition, a composition prepared from the method, and biomedical applications
06/19/2003WO2003050258A2 Endogenous retrovirus polypeptides linked to oncogenic transformation
06/19/2003WO2003050255A2 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
06/19/2003WO2003050248A2 Adenine nucleotide-binding protein-directed probes and methods of their synthesis and use
06/19/2003WO2003050237A2 Triazine library with linkers
06/19/2003WO2003050234A2 Method of immobilizing a biologic in a polyurethane-hydrogel composition, a composition prepared from the method, and biomedical applications
06/19/2003WO2003050143A1 Detection and removal of lead using lead-binding proteins
06/19/2003WO2003050140A1 Tumor antigens
06/19/2003WO2003050137A2 Toll-like receptor 4 mutations
06/19/2003WO2003050135A2 Use a parapox b2l protein to modify immune responses to administered antigens
06/19/2003WO2003050128A1 Phosphonates useful as modulators of t $g(g)9$g(d)2 lymphocyte activity
06/19/2003WO2003049936A1 Superparamagnetic nanostructured materials
06/19/2003WO2003049851A2 Microarray device
06/19/2003WO2003049773A1 Methods for inhibiting ocular processes
06/19/2003WO2003049768A1 Selective anesthetic agents and methods of identifying the same
06/19/2003WO2003049762A2 Immunisation against chlamydia trachomatis
06/19/2003WO2003049759A1 Agonists and antagonists of oxifan for the treatment of metabolic disorders
06/19/2003WO2003049758A1 Emergen agonists and antagonists for use in the treatment of metabolic disorders
06/19/2003WO2003049757A1 Agonists and antagonists of glucomin for the treatment of metabolic disorders
06/19/2003WO2003049756A1 Glucomin agonists and antagonists for use in the treatment of metabolic disorders
06/19/2003WO2003049723A2 Use of protease-activated receptor-2 inhibitor in the manifacture of a medicament for treating delayed hypersensitivity
06/19/2003WO2003049717A2 Conductance of improperly folded proteins through the secretory pathway and related treatments of diseases
06/19/2003WO2003049693A2 Method and composition for inducing weight loss
06/19/2003WO2003049686A2 Stabilization of hypoxia inducible factor (hif) alpha
06/19/2003WO2003049683A2 Use of parapox b2l protein to treat cancer and modify immune responses
06/19/2003WO2003049677A2 Mesoporous permeation layers for use on active electronic matrix devices
06/19/2003WO2003049671A2 Functionalized materials and libraries thereof
06/19/2003WO2003049602A2 Diagnostic methods for protein profiling
06/19/2003WO2003049599A2 Methods and compositions for the diagnosis of asthma
06/19/2003WO2003049595A2 Improved breath collection apparatus
06/19/2003WO2003049530A2 Method and apparatus for washing magnetically responsive particles
06/19/2003WO2003035681A3 Mycobacterial genes down-regulated during latency
06/19/2003WO2003027252A3 Isolated dna molecules encoding humanized calcitonin gene-related peptide receptor, related non-human transgenic animals and assay methods
06/19/2003WO2003014743A3 Use of dendrimers and poly-branched molecules to enhance signal in fluorescent assay systems
06/19/2003WO2003008977A3 Arrays of buffers for analysing biomolecules by their isoelectric point
06/19/2003WO2002099114A3 Methods to determine prognosis after therapy for bladder cancer
06/19/2003WO2002094864A3 Human cdnas and proteins and uses thereof
06/19/2003WO2002083846A9 Methods of analysis and labeling of protein-protein interactions
06/19/2003WO2002077237A3 Transporters and ion channels
06/19/2003WO2002061087A3 Antigenic peptides, such as for g protein-coupled receptors (gpcrs), antibodies thereto, and systems for identifying such antigenic peptides
06/19/2003WO2002044342A9 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof
06/19/2003WO2002034899A3 Tec kinase assay
06/19/2003WO2002029058A3 Human proteins, polynucleotides encoding them and methods of using the same
06/19/2003WO2002026815A3 Identification of neuroblastoma tumor suppressor genes
06/19/2003WO2002016648A3 Methods for external controls for nucleic acid amplification
06/19/2003WO2001027627A9 Assay device
06/19/2003WO2001008635A3 Calcium channel transport polynucleotides, polypeptides, and antibodies
06/19/2003US20030115634 Dna sequence from Plasmodium; detection of herbicides, viricides, bactericides, fungicides
06/19/2003US20030115616 Transgenic animal; urokinase plasminogen activator; viricides; detecting liver toxicity
06/19/2003US20030115030 Non-linear modelling of biological activity of chemical compounds
06/19/2003US20030114992 System and method to determine thermophysical properties of a multi-component gas at arbitrary temperature and pressure
06/19/2003US20030114991 Prediction of molecular polar surface area and bioabsorption
06/19/2003US20030114990 Prediction of molecular polar surface area and bioabsorption
06/19/2003US20030114785 Blood analyzing method and apparatus
06/19/2003US20030114762 Method and system for characterization and mapping of tissue lesions
06/19/2003US20030114659 Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors
06/19/2003US20030114652 Hybrid polypeptide; genetic engineering
06/19/2003US20030114651 Methods and reagents for preserving RNA in cell and tissue samples
06/19/2003US20030114646 Human cystatin F
06/19/2003US20030114510 Decreasing the membrane depolarization by antagonizing beta amyloid peptide aggregation
06/19/2003US20030114462 Drug abruse, alcoholism; respiratory system disorders, cardiovascular disorders
06/19/2003US20030114408 Testing the ability of a compound to modulate a nucleic acid expressing 86604 (transaminase) or a polypeptide having 86694 activity and therby identifying an antiproliferative agent; anticarcinogenic, -tumor agents
06/19/2003US20030114398 Monoclonal antiidiotype antibody 1A7 eliciting an anti-ganglioside GD2 response and overcomes immune tolerance; detecting an anti-GD2 antibody bound to a tumor cell; kits; melanoma, neuroblastoma, glioma, soft tissue sarcoma
06/19/2003US20030114382 Angiogenesis inhibition
06/19/2003US20030114375 Method for treating cystic fibrosis
06/19/2003US20030114357 Antidiabetic agents
1 ... 2566 2567 2568 2569 2570 2571 2572 2573 2574 2575 2576 2577 2578 2579 2580 2581 2582 2583 2584 2585 2586 ... 3937